Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders
Neuromyelitis optica spectrum disorders (NMOSDs) are caused by immunoglobulin G (IgG) autoantibodies directed against the water channel aquaporin-4 (AQP4). In NMOSDs, discrete clinical relapses lead to disability and are robustly prevented by the anti-CD20 therapeutic rituximab; however, its mechani...
Hlavní autoři: | Damato, V, Theorell, J, Al-Diwani, A, Kienzler, A-K, Makuch, M, Sun, B, Handel, A, Akdeniz, D, Berretta, A, Ramanathan, S, Fower, A, Whittam, D, Gibbons, E, McGlashan, N, Green, E, Huda, S, Woodhall, M, Palace, J, Sheerin, F, Waters, P, Leite, MI, Jacob, A, Irani, SR |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
National Academy of Sciences
2022
|
Podobné jednotky
-
Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
Autor: Wilson, R, a další
Vydáno: (2018) -
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Autor: Waters, P, a další
Vydáno: (2016) -
Immunological insights into the mechanisms by which RTX is effective in Neuromyelitis Optica spectrum disorders
Autor: Damato, V, a další
Vydáno: (2019) -
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
Autor: Kitley, J, a další
Vydáno: (2013) -
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Autor: Kitley, J, a další
Vydáno: (2013)